NCT00057369View on ClinicalTrials.gov

Safety and Efficacy of Dalbavancin Versus Vancomycin in the Treatment of Catheter-Related Bloodstream Infections

PHASE2UnknownINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

February 28, 2001

Study Completion Date

June 30, 2003

Conditions
Bacteremia
Interventions
DRUG

dalbavancin

Trial Locations (1)

30060

Wellstar/Kennestone Hospital, Marietta

Sponsors
All Listed Sponsors
lead

Vicuron Pharmaceuticals

INDUSTRY